Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS – RECORD FY2019 CONSOLIDATED REVENUES OF $32.8 M, UP 36%, RECORD FFR REVENUES OF $20 M, UP 41%

14 November 2019

OPSENS – RECORD FY2019 CONSOLIDATED REVENUES OF $32.8 M, UP 36%, RECORD FFR REVENUES OF $20 M, UP 41% Quebec City, Quebec, November 14, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for 2019. Highlights FOR THE QUARTER AND FOR THE YEAR Record consolidated revenues at $32.8 M for…

Read more

OPSENS ANNOUNCES ENTRY INTO STRUCTURAL HEART MARKET

5 November 2019

OPSENS ANNOUNCES ENTRY INTO STRUCTURAL HEART MARKET Expands core technology into fastest growing segment of cardiology devices Quebec City, Quebec, November 5, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) announces today it is expanding its medical device business into the structural cardiology space and will accelerate development activities of products that reach…

Read more

Visit Opsens at TCT 2019

4 September 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at TCT 2019 (Transcatheter Cardiovascular Therapeutics 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more

OPSENS – Q3 2019 – RECORD QUARTERLY FFR REVENUES OF $5.2 M, UP 49%

11 July 2019

Quebec City, Quebec, July 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today reported its results for the third quarter of 2019. Highlights Consolidated revenues of $7.9 M for the third quarter of 2019 compared with $6.4 M for the third quarter of 2018, an increase of $1.5 M or 23%; Fractional…

Read more

Visit Opsens at CVI 2019

2 July 2019

Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at CVI 2019 (Cardiovascular Innovations 2019) by attending Opsens’ complimentary lunch  and educational symposium. Register Now! The OptoWire features a large nitinol core with excellent torque response and deliverability. With the OptoWire you can diagnose and treat your patients with…

Read more

Learn from coronary physiology KOLs after EuroPCR 2019

30 June 2019
EuroPCR 2019 - Emanuele Barbota EuroPCR 2019 - Morton J Kern

OPSENS SOLUTIONS PARTNERS WITH TEMAI INGENIEROS FOR THE COMMISSIONING OF AN OPTICAL-BASED FUEL MONITORING SYSTEM FOR A MAJOR AIRCRAFT MANUFACTURER

17 June 2019

Paris – Le Bourget, France, June 17, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that Opsens Solutions Inc. (“Opsens Solutions”), its wholly-owned subsidiary, is partnering with Temai Ingenieros S.L.  (“Temai”) for the commissioning of an optical-based fuel monitoring system for a major aircraft manufacturer. This agreement comes after over a…

Read more

OPSENS SOLUTIONS FURTHER EXPANDS INTELLECTUAL PROPERTY PORTFOLIO WITH USPTO GRANT

11 June 2019

Quebec City, Quebec, June 11, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that its wholly-owned subsidiary Opsens Solutions Inc. (“Opsens Solutions”), has been granted a patent for an innovative optical-based pressure sensor from the United States Patent and Trademark Office (“USPTO”). Patent no. 10,082,437 entitled “Optical Pressure Sensor with Reduced…

Read more

Visit Opsens Solutions at the SIAE Le Bourget 2019

7 June 2019

Opsens Solutions will be exhibiting at the SIAE Le Bourget 2019, the International Paris Airshow, in France from June 17-23. Please come to visit us at booth C80, Hall 3

OPSENS TO PRESENT AT THE LD MICRO INVITATIONAL

22 May 2019

Quebec City, Quebec, May 22, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a company focusing mainly on physiological measurements such as Fractional Flow Reserve (“FFR”) and Diastolic Pressure Ratio (“dPR”) in interventional cardiology, will present at the LD Micro 9th Invitational investor conference on Tuesday, June 4, 2019 at 8:40 am PST. Louis Laflamme, Opsens’…

Read more